• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Rarebreed Veterinary Partners Acquires Maine Veterinary Medical Center

Share:

March 9, 2020

Rarebreed Veterinary Partners, a technology-enabled animal health startup based in Portland, Maine, announced today that it has acquired Maine Veterinary Medical Center (MVMC), a specialty/referral hospital offering advanced medical care for pets, including neurology, internal medicine, oncology, ophthalmology, surgery, rehabilitation, emergency care and critical care. Deal terms have not been disclosed.

MVMC employs 150 veterinary professionals, including 21 specialty doctors and is located in a 20,000-square-foot hospital in Scarborough, Maine. The state-of-the art facility includes a newly completed 2,500-square-foot intensive care unit and a large collection of advanced veterinary medical equipment, including Maine’s only veterinary MRI and fluoroscopy suite.

“Our entire team is thrilled that MVMC’s leadership believed in Rarebreed and chose our model over other bidders offering more money,” said Rarebreed CEO Dan Espinal. “This partnership puts Rarebreed on the cutting edge of veterinary medicine and gets us into the specialty business.”

As part of the deal, 21 MVMC doctors and a collection of staff will take ownership in the company, along with Rarebreed, which acquired the majority share.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

MVMC chief of staff Ezra J Steinberg, VMD, DACVS, noted that MVMC met with multiple potential partners before choosing Rarebreed. “A primary reason for selecting Rarebreed is their commitment to preserve local control and offering equity to interested doctors and staff,” said Dr. Steinberg. “The ownership aspect of this agreement is really exciting because it means that our staff will get to participate in the economic upside of the business.”

Rarebreed Captures New Investment

Since its founding in 2018, Rarebreed has grown to 450 employees, with $40 million in revenue. In February 2020, the company announced it had raised $42 million in two rounds of equity financing including investments by Caremi Partners Limited and Northwood Investors LLC.

Rarebreed is focused on taking care of the people who take care of animals with the goal of becoming the employer of choice for those dedicating their professional lives to veterinary care. Rarebreed accomplishes this by bringing industry leading benefits to bear, including outsized parental leave, pet medical benefits, and best-in-class healthcare benefits for anyone working more than 30 hours a week. Rarebreed invests in business operations and a technology backend that provides deep analytics into the practice.

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Lexicon Pharmaceuticals Completes the Sale of XERMELO to TerSera TherapeuticsLexicon Pharmaceuticals Completes the Sale of XERMELO to TerSera Therapeutics
  • Top News Surrounding AI in HealthcareTop News Surrounding AI in Healthcare
  • BioMed Realty Acquires Flagship Property in Boston’s Seaport DistrictBioMed Realty Acquires Flagship Property in Boston’s Seaport District
  • Amgen, Astellas to pay government nearly $125M to resolve copay kickback allegationsAmgen, Astellas to pay government nearly $125M to resolve copay kickback allegations
  • ClearPoint Neuro, Inc. Announces License and Research Agreement with PhilipsClearPoint Neuro, Inc. Announces License and Research Agreement with Philips
  • Wesfarmers Offers $90M to Buy Telehealth Firm InstantScripts.Wesfarmers Offers $90M to Buy Telehealth Firm InstantScripts.
  • Biosimilars: Top 10 Pharma Companies Leading the WayBiosimilars: Top 10 Pharma Companies Leading the Way
  • Spectrum Health Taps TytoCare to Expand Telehealth OfferingsSpectrum Health Taps TytoCare to Expand Telehealth Offerings

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications